657 related articles for article (PubMed ID: 26723910)
21. Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction.
Noureldein MH; Eid AA
Microb Pathog; 2018 May; 118():98-104. PubMed ID: 29548696
[TBL] [Abstract][Full Text] [Related]
22. Nanotoxicity of engineered nanomaterials (ENMs) to environmentally relevant beneficial soil bacteria - a critical review.
Lewis RW; Bertsch PM; McNear DH
Nanotoxicology; 2019 Apr; 13(3):392-428. PubMed ID: 30760121
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiome and Antibiotics.
Iizumi T; Battaglia T; Ruiz V; Perez Perez GI
Arch Med Res; 2017 Nov; 48(8):727-734. PubMed ID: 29221800
[TBL] [Abstract][Full Text] [Related]
24. Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections.
Denny JE; Powell WL; Schmidt NW
Front Cell Infect Microbiol; 2016; 6():41. PubMed ID: 27148490
[TBL] [Abstract][Full Text] [Related]
25. The gut microbiota and its potential role in obesity.
Shabana ; Shahid SU; Irfan U
Future Microbiol; 2018 Apr; 13():589-603. PubMed ID: 29533087
[TBL] [Abstract][Full Text] [Related]
26. Challenges in simulating the human gut for understanding the role of the microbiota in obesity.
Aguirre M; Venema K
Benef Microbes; 2017 Feb; 8(1):31-53. PubMed ID: 27903093
[TBL] [Abstract][Full Text] [Related]
27. New insights into the interactions between Blastocystis, the gut microbiota, and host immunity.
Deng L; Wojciech L; Gascoigne NRJ; Peng G; Tan KSW
PLoS Pathog; 2021 Feb; 17(2):e1009253. PubMed ID: 33630979
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiome: Microflora association with obesity and obesity-related comorbidities.
Lone JB; Koh WY; Parray HA; Paek WK; Lim J; Rather IA; Jan AT
Microb Pathog; 2018 Nov; 124():266-271. PubMed ID: 30138755
[TBL] [Abstract][Full Text] [Related]
29. Ingested engineered nanomaterials: state of science in nanotoxicity testing and future research needs.
Sohal IS; O'Fallon KS; Gaines P; Demokritou P; Bello D
Part Fibre Toxicol; 2018 Jul; 15(1):29. PubMed ID: 29970114
[TBL] [Abstract][Full Text] [Related]
30. Sex-Specific Effects of Arsenic Exposure on the Trajectory and Function of the Gut Microbiome.
Chi L; Bian X; Gao B; Ru H; Tu P; Lu K
Chem Res Toxicol; 2016 Jun; 29(6):949-51. PubMed ID: 27268458
[TBL] [Abstract][Full Text] [Related]
31. Developmental toxicity of engineered nanomaterials in rodents.
Ema M; Gamo M; Honda K
Toxicol Appl Pharmacol; 2016 May; 299():47-52. PubMed ID: 26721308
[TBL] [Abstract][Full Text] [Related]
32. The effects of metformin on gut microbiota and the immune system as research frontiers.
Pollak M
Diabetologia; 2017 Sep; 60(9):1662-1667. PubMed ID: 28770326
[TBL] [Abstract][Full Text] [Related]
33. Effects of dietary exposure to the engineered nanomaterials CeO
Bredeck G; Kämpfer AAM; Sofranko A; Wahle T; Lison D; Ambroise J; Stahlmecke B; Albrecht C; Schins RPF
Nanotoxicology; 2021 Sep; 15(7):934-950. PubMed ID: 34380002
[TBL] [Abstract][Full Text] [Related]
34. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity.
Secombe KR; Coller JK; Gibson RJ; Wardill HR; Bowen JM
Int J Cancer; 2019 May; 144(10):2365-2376. PubMed ID: 30155890
[TBL] [Abstract][Full Text] [Related]
35. [Effects of Gut Microbiota on Stress Response and Behavioral Phenotype of the Host].
Sudo N
Brain Nerve; 2016 Jun; 68(6):595-605. PubMed ID: 27279157
[TBL] [Abstract][Full Text] [Related]
36. Gut Microbiota and Coronary Artery Disease.
Yamashita T; Emoto T; Sasaki N; Hirata KI
Int Heart J; 2016 Dec; 57(6):663-671. PubMed ID: 27818484
[TBL] [Abstract][Full Text] [Related]
37. Intestinal IgA as a modulator of the gut microbiota.
Okai S; Usui F; Ohta M; Mori H; Kurokawa K; Matsumoto S; Kato T; Miyauchi E; Ohno H; Shinkura R
Gut Microbes; 2017 Sep; 8(5):486-492. PubMed ID: 28384049
[TBL] [Abstract][Full Text] [Related]
38. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.
Koopen AM; Groen AK; Nieuwdorp M
Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197
[TBL] [Abstract][Full Text] [Related]
39. Neurotoxicity of Engineered Nanomaterials: Testing Considerations.
Scarcello E; Sofranko A; Wahle T; Schins RPF
Front Public Health; 2022; 10():904544. PubMed ID: 35910929
[TBL] [Abstract][Full Text] [Related]
40. Microbiota, obesity and malnutrition.
Raoult D
Microb Pathog; 2017 May; 106():1-2. PubMed ID: 26911645
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
